PPLPHARMA · Concall Summary
PIRAMAL PHARMA LIMITED
Piramal Pharma Limited provided a transcript of its conference call regarding the unaudited financial results for the quarter ended 30th June 2026. The document included details about the call held on 30th July 2026, which discussed both standalone and consolidated financial results. The company referenced a previous communication dated 20th July 2026 and noted that the transcript is accessible on its website. The correspondence was signed by Maneesh Sharma, the Company Secretary and Compliance Officer.
The document presented factual information regarding the conference call and financial results without emphasizing any particular sentiment.
View source filing →Earlier concalls
- 2026-07-29 — Piramal Pharma Limited announced its unaudited financial results for the first quarter of FY27, reporting a 17% increase…
- 2026-04-30 — Piramal Pharma Limited provided a transcript of its conference call held on 29th April 2026, discussing the audited fina…
- 2026-04-28 — Piramal Pharma Limited announced its audited financial results for Q4 and FY26, reporting a consolidated revenue from op…
See PPLPHARMA's full Research Pro page — annual report summary, insider trades, promoter pledge trend, options positioning and Ask-RedixFi AI.
Sign up free